www.verygoodnewsisrael.blogspot.com
At the start of a new calendar year, Israelis continue to bring new innovations into the world to benefit humanity. A new heart implant, a new treatment for Parkinson’s, a new sleep quality analyzer, and a successful Israeli cancer treatment is launched. New social initiatives include for the disabled, Arab-Israeli coexistence and public diplomacy. New technology for solar cells, renewable energy storage, smart mobility, cyber security, animal-free meat, healthy soil and optical lenses. New programs and deals to generate and expand Israeli businesses. New cultural, entertainment and sporting successes. There are so many new reasons to look forward to a Very Good 2022. Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Implant for congestive heart failure patients. Israel’s Restore Medical develops the ContraBand implant that uses the patient’s Left Ventrical to assist a failing Right Ventrical for the treatment of congestive heart failure (CHF). It has just announced promising preliminary results of its First-in-Human clinical trials.
https://www.israelhayom.com/2021/12/01/israels-restore-medical-announces-first-in-human-trial-of-heart-failure-treatment/ https://restoremedical.co/
Boost for Parkinson’s treatment. Back in 2013 (see here previously) Tel Aviv University researchers found that the sugar substitute mannitol could protect the brain against Parkinson’s disease. But a trial could not get funding. So, entrepreneur and Parkinson’s sufferer Dan Vesely co-founded and crowdfunded CliniCrowd.
https://www.israelnationalnews.com/news/318928 https://clinicrowd.info/
https://www.youtube.com/watch?v=vo6z6OQsBRM
Israel starts trial of 4th vaccination. Israel’s Sheba Medical Center has begun the first study in the world of the efficacy of administering a fourth dose of the coronavirus vaccine. The 6,000 participants include 150 medical personnel who had a 3rd dose in August. They will receive the Pfizer vaccine.
https://www.timesofisrael.com/israeli-hospital-to-begin-study-on-efficacy-of-4th-covid-vaccine-dose/
How plants fight infections. Scientists at Israel’s Weizmann Institute have identified the complex way that plant bacteria fight off infections from viruses known as phages. A protein in the bacteria calls another protein to destroy a molecule inside itself that the phage needs to replicate. The cell dies but it stops the infection.
https://wis-wander.weizmann.ac.il/life-sciences/bacteria-and-plants-fight-alike
Monitor your sleep at home. (TY Hazel) No need to go to a sleep lab to analyze your sleep problems. The electrophysiological measurement solution from Israel’s X-trodes (see here previously) is ideal for home use. Its smart skin electrodes measure brainwaves, eye movement, skeletal muscles, cardiac activity and more.
https://www.israel21c.org/skip-the-sleep-lab-and-go-wireless-at-home/
9 top digital health companies. (TY Hazel) CB Insights has named nine Israeli-based health-tech startups in its 2021 Top 150 Digital Health Companies transforming healthcare. They include Vocalis, Sweetch, DiA Imaging, B.Well, C2I Genomics, Lumen, Nym Health, Theator and Empathy.
https://www.israel21c.org/8-israeli-startups-make-cb-insights-top-150-list/ https://b-well.co.il/ (Hebrew)
Israeli startups transforming telehealth. Some more innovative Israeli healthcare startups. Those not previously reported in this newsletter are medFlyt (caregiver management) and Sivan Innovation (Moovcare patient / physician communications) https://www.calcalistech.com/ctech/articles/0,7340,L-3921246,00.html
https://www.medflyt.com/ https://vimeo.com/469424965 https://www.sivan-innovation.com/
$17 million for digital health. Israel has budgeted NIS 55 million for hospitals and health organizations etc., to build the digital infrastructure required for anonymized medical data sharing. It will spearhead major advances in groundbreaking research and innovative development by Israeli healthcare startups and research scientists.
https://www.timesofisrael.com/israel-earmarks-17m-for-new-digital-health-innovation-program/
Cancer treatment goes into space. A SpaceX Falcon 9 rocket took off for the International Space Station carrying a smart laboratory developed by Israel’s SpacePharma. It will test Doxil from Israel’s Ayana to see its effect on cells in zero gravity. Doxil is the first nanotechnology cancer treatment approved by the US FDA.
https://www.calcalistech.com/ctech/articles/0,7340,L-3925795,00.html